Last reviewed · How we verify
Reference Medicinal Product
At a glance
| Generic name | Reference Medicinal Product |
|---|---|
| Also known as | EU Orencia |
| Sponsor | Dr. Reddy's Laboratories Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Procedural Framing and Epidural Steroid Injection Outcomes (NA)
- Food as Medicine Study (NA)
- The Impact of Music Medicine on Preterm Brain Development and Behavior (NA)
- Human Bioequivalence Study of Liposomal Amphotericin B for Injection (NA)
- Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets (PHASE1)
- Buddhist Awareness Training Program and Qigong Psychosocial Interventions for People With Insomnia (NA)
- High-Resolution CT for Heart
- Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reference Medicinal Product CI brief — competitive landscape report
- Reference Medicinal Product updates RSS · CI watch RSS
- Dr. Reddy's Laboratories Limited portfolio CI